Curosurf 240Mg/3.0Ml Inj

Written By Bayyarapu Mahesh Kumar , M Pharmacy

Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

MRP ₹21349.5

(Inclusive of all Taxes)

₹2134.9 Cashback (10%)

Provide Delivery Location

Non returnable*

Know More

COD available

Online payment accepted

Prescription drug

Whats That

About Curosurf 240Mg/3.0Ml Inj

Curosurf 240Mg/3.0Ml Inj belongs to a class of drugs called pulmonary surfactants. It is used to treat premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient surfactant in the lungs.

Curosurf 240Mg/3.0Ml Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will help your baby breathe normally until it produces its own surfactant.

Curosurf 240Mg/3.0Ml Inj will be given to your baby in a hospital by a suitably trained doctor. In some cases, Curosurf 240Mg/3.0Ml Inj may cause a slow heart rate, low blood pressure, endotracheal tube blockage, and low blood oxygen levels.

The administration of Curosurf 240Mg/3.0Ml Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with Curosurf 240Mg/3.0Ml Inj, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.

Uses of Curosurf 240Mg/3.0Ml Inj

Respiratory distress syndrome (RDS)

Directions for Use

Curosurf 240Mg/3.0Ml Inj will be given to your baby in a hospital by a trained healthcare professional.

Medicinal Benefits

Curosurf 240Mg/3.0Ml Inj is a pulmonary surfactant. It is used to treat premature infants who have or are at risk of developing respiratory distress syndrome (RDS). Curosurf 240Mg/3.0Ml Inj contains Poractant Alfa, a natural surfactant that works similarly to human surfactant. As a result, it will assist your baby in breathing normally until they develop their own surfactant.

Drug Warnings

Before using Curosurf 240Mg/3.0Ml Inj, let your doctor know about all your children's medical conditions, sensitivities, and all medications used. The administration of Curosurf 240Mg/3.0Ml Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby experiences any issues while being treated with Curosurf 240Mg/3.0Ml Inj, contact your doctor as soon as possible, even if you do not feel the problem is due to the medication.

Diet & Lifestyle Advise

NA

Side Effects of Curosurf 240Mg/3.0Ml Inj

Bradycardia (a slow heart rate)
Hypotension (low blood pressure)
endotracheal tube blockage
oxygen desaturation (drops in blood oxygen level)

Habit Forming

No

Therapeutic Class

LUNG SURFACTANTS

Author Details

Written By

Bayyarapu Mahesh Kumar

M Pharmacy

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 8, 2025 | 9:49 AM IST

We provide you with authentic, trustworthy and relevant information

FAQs

How does Curosurf 240Mg/3.0Ml Inj work?

Curosurf 240Mg/3.0Ml Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will, therefore, help your baby to breathe normally until your baby produces their own surfactant.

Is it ideal to use in all premature babies?

No, it is not necessary to use in all premature babies. It can be used only in premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS).

What is Poractant Alfa used for?

Please inform your doctor if your child has a history of liver diseases/conditions. Your doctor will weigh the benefits and potential risks before prescribing Curosurf 240Mg/3.0Ml Inj.Poractant Alfa is used to treat or prevent lung distress in premature babies.

Disease/Condition Glossary

Respiratory distress syndrome (RDS): RDS is mainly caused when the baby's lungs do not have enough surfactant. The earlier the infant is born, the more probable they may have RDS. Under such conditions, the baby requires extra oxygen, which is done through ventilatory support.